Curis (CRIS) EBIAT (2016 - 2025)
Curis (CRIS) has disclosed EBIAT for 16 consecutive years, with -$7.7 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EBIAT rose 23.33% year-over-year to -$7.7 million, compared with a TTM value of -$36.6 million through Sep 2025, up 19.61%, and an annual FY2024 reading of -$43.4 million, up 8.49% over the prior year.
- EBIAT was -$7.7 million for Q3 2025 at Curis, up from -$8.6 million in the prior quarter.
- Across five years, EBIAT topped out at -$7.7 million in Q3 2025 and bottomed at -$16.1 million in Q1 2022.
- Average EBIAT over 5 years is -$11.6 million, with a median of -$11.6 million recorded in 2023.
- The sharpest move saw EBIAT crashed 84.98% in 2021, then increased 28.25% in 2023.
- Year by year, EBIAT stood at -$13.6 million in 2021, then increased by 16.82% to -$11.3 million in 2022, then dropped by 3.38% to -$11.7 million in 2023, then rose by 17.88% to -$9.6 million in 2024, then rose by 19.55% to -$7.7 million in 2025.
- Business Quant data shows EBIAT for CRIS at -$7.7 million in Q3 2025, -$8.6 million in Q2 2025, and -$10.6 million in Q1 2025.